Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ria

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
World Journal of Stem Cells|January 27, 2015
Identify multiple myeloma stem cells: Utopia?Ilaria Saltarella, Aurelia Lamanuzzi, Antonia Reale, et al.
Current Drug Targets. Inflammation and Allergy|February 22, 2005
Development of vasculature targeting strategies for the treatment of chronic inflammatory diseasesGirolamo Ranieri, Roberto Ria, Aldo M Roccaro, et al.
Discover Oncology|March 26, 2025
Successful rapid desensitization to zoledronic acid in a multiple myeloma patientFederico Spataro, Antonio Giovanni Solimando, Vanessa Desantis, et al.
Clinical and Experimental Medicine|March 5, 2013
Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicineFranco Dammacco, Angelo Vacca, Pasquale Procaccio, et al.
Clinical and Experimental Medicine|April 12, 2014
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignanciesRoberto Ria, Antonia Reale, Assunta Melaccio, et al.
European Journal of Clinical Investigation|October 10, 2024
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta-analysis of eight studiesFederico Spataro, Antonio Giovanni Solimando, Attilio Di Girolamo, et al.
International Journal of Dermatology|March 22, 2025
Dupilumab for the Treatment of Post-Scabies Prurigo (PSP): A Case ReportMichelina Francesca Daddato, Federico Spataro, Eustachio Nettis, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 11, 2008
Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing lossNicola Quaranta, Alfonso Ramunni, Paola Brescia, et al.
International Journal of Clinical and Experimental Medicine|December 14, 2012
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agentsRoberto Ria, Antonia Reale, Michele Moschetta, et al.
Clinical Immunology (Orlando, Fla.)|December 2, 2017
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trialAngelo Vacca, Assunta Melaccio, Azzurra Sportelli, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
World Journal of Stem Cells|January 27, 2015
Identify multiple myeloma stem cells: Utopia?Ilaria Saltarella, Aurelia Lamanuzzi, Antonia Reale, et al.
Current Drug Targets. Inflammation and Allergy|February 22, 2005
Development of vasculature targeting strategies for the treatment of chronic inflammatory diseasesGirolamo Ranieri, Roberto Ria, Aldo M Roccaro, et al.
Discover Oncology|March 26, 2025
Successful rapid desensitization to zoledronic acid in a multiple myeloma patientFederico Spataro, Antonio Giovanni Solimando, Vanessa Desantis, et al.
Clinical and Experimental Medicine|March 5, 2013
Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicineFranco Dammacco, Angelo Vacca, Pasquale Procaccio, et al.
Clinical and Experimental Medicine|April 12, 2014
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignanciesRoberto Ria, Antonia Reale, Assunta Melaccio, et al.
European Journal of Clinical Investigation|October 10, 2024
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta-analysis of eight studiesFederico Spataro, Antonio Giovanni Solimando, Attilio Di Girolamo, et al.
International Journal of Dermatology|March 22, 2025
Dupilumab for the Treatment of Post-Scabies Prurigo (PSP): A Case ReportMichelina Francesca Daddato, Federico Spataro, Eustachio Nettis, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 11, 2008
Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing lossNicola Quaranta, Alfonso Ramunni, Paola Brescia, et al.
International Journal of Clinical and Experimental Medicine|December 14, 2012
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agentsRoberto Ria, Antonia Reale, Michele Moschetta, et al.
Clinical Immunology (Orlando, Fla.)|December 2, 2017
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trialAngelo Vacca, Assunta Melaccio, Azzurra Sportelli, et al.
Pageof 14